Evidence map›Paper›PMID 41061181›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2025

APOSTEL-R Recommendations for Reporting Retinal Optical Coherence Tomography Studies in Rodents.

Frederike Cosima Oertel, Delia Cabrera Debuc, Peter A Calabresi, Mei Chen, Christian Cordano, Michael Dietrich, Nicolas Feltgen, Oliver Gramlich, Ari J Green, Janos Groh and 22 more

Abstract read
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Frederike Cosima OertelExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.ORCID 0000-0003-4906-5983
Delia Cabrera DebucBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, FL.
Peter A CalabresiMultiple Sclerosis Center, Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD.ORCID 0000-0002-7776-6472
Mei ChenWellcome Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, United Kingdom.ORCID 0000-0001-5661-1386
Christian CordanoWeill Institute for Neurosciences, University of California San Francisco, CA.ORCID 0000-0002-1413-0442
Michael DietrichDepartment of Neurology, University Hospital and Medical Faculty of Heinrich-Heine-Universität Düsseldorf, Germany.
Nicolas FeltgenDepartment of Ophthalmology, Universitätsspital Basel, Switzerland.
Oliver GramlichDepartment of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, IA.ORCID 0000-0001-6948-0522
Ari J GreenWeill Institute for Neurosciences, University of California San Francisco, CA.ORCID 0000-0001-9275-3066
Janos GrohInstitute of Neuronal Cell Biology, Technical University Munich, Germany.ORCID 0000-0002-7628-0163
Su-Chun HuangDepartment of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Italy.ORCID 0000-0002-7359-6736
Benjamin KnierDepartment of Neurology, TUM School of Medicine an Health, Technical University Munich, Germany.ORCID 0000-0003-4187-9472
Thomas KornDepartment of Neurology, TUM School of Medicine an Health, Technical University Munich, Germany.ORCID 0000-0002-3633-0955
Letizia LeocaniUniversity Vita-Salute San Raffaele, Milan, Italy.ORCID 0000-0001-9326-6753
Anat LoewensteinDivision of Ophthalmology, Tel Aviv Medical Center, Tel Aviv University, Israel.
Christian van OterendorpDepartment of Ophthalmology, Universitätsmedizin Göttingen, Germany.
Tunde PetoCentre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, United Kingdom.
Sven SchipplingDepartment of Neurology, University Hospital Zurich, Switzerland.
Leopold SchmettererCenter for Medical Physics and Biomedical Engineering, Medical University Vienna, Austria.
Steffen Schmitz-ValckenbergExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
Mathias W SeeligerDivision of Ocular Neurodegeneration, Institute for Ophthalmic Research, Centre for Ophthalmology, Eberhard Karls University, Tübingen, Germany.ORCID 0000-0002-7879-6788
Kenneth S ShindlerScheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0003-2417-258X
Joel S SchumanAdvanced Center for Ophthalmic Research in Neuroimaging (ACORN), Vickie and Jack Farber Vision Research Center, Philadelphia, PA.ORCID 0000-0002-8885-3766
Mustafa SindiDepartment of Neurology, University Hospital and Medical Faculty of Heinrich-Heine-Universität Düsseldorf, Germany.ORCID 0009-0008-2890-2336
Adnan TufailDepartment of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, United Kingdom.
Jui-Kai WangDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas.ORCID 0000-0001-8308-8455
Sebastian WolfDepartment of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Switzerland.ORCID 0000-0002-7467-7028
Yuyi YouMacquarie Medical School, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.ORCID 0000-0002-0175-3018
Martin ZinkernagelDepartment of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Wolf LagrèzeDepartment of Ophthalmology, Universitätsklinikum Freiburg, Germany; and.ORCID 0000-0002-3558-5905
Philipp AlbrechtDepartment of Neurology, University Hospital and Medical Faculty of Heinrich-Heine-Universität Düsseldorf, Germany.ORCID 0000-0001-7987-658X
IMSVISUAL consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesRetinal optical coherence tomography (OCT) in rodent models has been used to longitudinally image retinal changes, to define end points for more costly or time-consuming experiments, and to better understand the pathophysiology underlying OCT findings in human diseases. No standardization of rodent OCT reporting currently exists. Here, we aim to establish consensus recommendation for reporting results from retinal OCT studies in rodents.

methodsInitial recommendations were developed based on the APOSTEL criteria for quantitative OCT reporting in humans by a core team. Using a modified Delphi process, an expert panel of rodent OCT researchers (N = 31) and the wider scientific community discussed, refined, and voted on these initial recommendations. The list of recommendations was then revised and approved by the expert panel.

resultsThe final 7-point checklist includes reporting recommendations regarding the study protocol, OCT device, acquisition settings and modifications, scanning protocol, funduscopic imaging, postacquisition data selection and image data analyses, and qualitative and quantitative results. With a median agreement score of 3 or 4 out of 4, the scientific community agreed with these recommendations. After revisions, the expert panel accepted the final recommendations. DISCUSSION: The Advised Protocol for OCT Study Terminology and Elements for reporting OCT studies in rodents (APOSTEL-R) originates from an expert consensus. They will provide guidance throughout the experimental process and will contribute to the standardization and quality improvement of preclinical OCT studies.

Indexed as

RetinaTomography, Optical CoherenceAnimalsConsensusRatsRodentia

Identifiers

PMID41061181
PMCPMC12509961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.